Globus Medical, Inc. (GMED)
76.49
+1.07
(+1.42%)
USD |
NYSE |
Jul 24, 16:00
76.43
-0.06
(-0.08%)
After-Hours: 20:00
Globus Medical Cash from Investing (Quarterly) : -182.67M for March 31, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | -182.67M |
| December 31, 2025 | -111.45M |
| September 30, 2025 | -75.84M |
| June 30, 2025 | -299.11M |
| March 31, 2025 | 131.38M |
| December 31, 2024 | -104.12M |
| September 30, 2024 | -14.97M |
| June 30, 2024 | -10.38M |
| March 31, 2024 | -46.58M |
| December 31, 2023 | 320.62M |
| September 30, 2023 | -80.86M |
| June 30, 2023 | 52.22M |
| March 31, 2023 | 10.99M |
| December 31, 2022 | -60.48M |
| September 30, 2022 | -63.11M |
| June 30, 2022 | 27.13M |
| March 31, 2022 | -13.89M |
| December 31, 2021 | -243.80M |
| September 30, 2021 | -6.885M |
| June 30, 2021 | -0.143M |
| March 31, 2021 | -125.11M |
| December 31, 2020 | -119.09M |
| September 30, 2020 | 7.661M |
| June 30, 2020 | -3.299M |
| March 31, 2020 | -2.592M |
| Date | Value |
|---|---|
| December 31, 2019 | -36.04M |
| September 30, 2019 | -13.67M |
| June 30, 2019 | -36.74M |
| March 31, 2019 | -53.84M |
| December 31, 2018 | -52.62M |
| September 30, 2018 | -28.86M |
| June 30, 2018 | -55.43M |
| March 31, 2018 | -56.11M |
| December 31, 2017 | -16.31M |
| September 30, 2017 | -36.21M |
| June 30, 2017 | -47.83M |
| March 31, 2017 | -10.93M |
| December 31, 2016 | -6.408M |
| September 30, 2016 | -46.21M |
| June 30, 2016 | -10.81M |
| March 31, 2016 | -36.12M |
| December 31, 2015 | -35.41M |
| September 30, 2015 | -22.84M |
| June 30, 2015 | -48.52M |
| March 31, 2015 | -43.78M |
| December 31, 2014 | -91.43M |
| September 30, 2014 | -3.774M |
| June 30, 2014 | 16.18M |
| March 31, 2014 | -20.98M |
| December 31, 2013 | -45.91M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Intuitive Surgical, Inc. | -26.60M |
| Stryker Corp. | -185.00M |
| Zimmer Biomet Holdings, Inc. | -159.00M |
| Abbott Laboratories | -- |
| DexCom, Inc. | -298.50M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 202.36M |
| Cash from Financing (Quarterly) | 18.20M |
| Free Cash Flow | 605.57M |
| Free Cash Flow Per Share (Quarterly) | 1.178 |
| Free Cash Flow to Equity (Quarterly) | 166.25M |
| Free Cash Flow to Firm (Quarterly) | 162.75M |
| Free Cash Flow Yield | 5.79% |